Publication | Closed Access

A Phase II and Pharmacokinetic Study of Weekly 72-h Topotecan Infusion in Patients with Platinum-Resistant and Paclitaxel-Resistant Ovarian Carcinoma

OncologyPaclitaxel-resistant Ovarian CarcinomaMedicinePharmacokinetic StudyGynecologyPharmacotherapyTumor TargetingCancer TreatmentPharmacologyPhase IiGynecology OncologyOvarian Cancer